Literature DB >> 19419941

A comparison of cytokine production in 2-dimensional and 3-dimensional cultures of bone marrow stromal cells of multiple myeloma patients in response to RPMI8226 myeloma cells.

Barbara Zdzisińska1, Jacek Roliński, Tomasz Piersiak, Martyna Kandefer-Szerszeń.   

Abstract

We examined cytokine production by bone marrow stromal cells (BMSCs) of patients with multiple myeloma (MM) in response to contact with myeloma RPMI8226 cells in standard 2-dimensional (2D) cultures and in 3-dimensional (3D) cultures on a gelatine sponge scaffold. It was detected that BMSCs in the 3D cultures produced more IL-11 and HGF and less IL-10 than in the 2D cultures. Moreover, RPMI8226 cells after contact with BMSCs in 3D cultures produced more sIL-6R than in the classic 2D cultures. We concluded that 3D cultures of BMSCs with myeloma cells offered a promising model for in vitro examination of interactions between myeloma cells and the bone marrow stroma and for examination of potent antimyeloma agents.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19419941     DOI: 10.2478/v10042-009-0015-1

Source DB:  PubMed          Journal:  Folia Histochem Cytobiol        ISSN: 0239-8508            Impact factor:   1.698


  7 in total

Review 1.  Multiple myeloma mesenchymal stem cells: characterization, origin, and tumor-promoting effects.

Authors:  Michaela R Reagan; Irene M Ghobrial
Journal:  Clin Cancer Res       Date:  2011-11-07       Impact factor: 12.531

2.  3D tissue-engineered bone marrow as a novel model to study pathophysiology and drug resistance in multiple myeloma.

Authors:  Pilar de la Puente; Barbara Muz; Rebecca C Gilson; Feda Azab; Micah Luderer; Justin King; Samuel Achilefu; Ravi Vij; Abdel Kareem Azab
Journal:  Biomaterials       Date:  2015-09-12       Impact factor: 12.479

3.  Investigating osteogenic differentiation in multiple myeloma using a novel 3D bone marrow niche model.

Authors:  Michaela R Reagan; Yuji Mishima; Siobhan V Glavey; Yong Zhang; Salomon Manier; Zhi Ning Lu; Masoumeh Memarzadeh; Yu Zhang; Antonio Sacco; Yosra Aljawai; Jiantao Shi; Yu-Tzu Tai; John E Ready; David L Kaplan; Aldo M Roccaro; Irene M Ghobrial
Journal:  Blood       Date:  2014-09-09       Impact factor: 22.113

4.  A novel 3D mesenchymal stem cell model of the multiple myeloma bone marrow niche: biologic and clinical applications.

Authors:  Jana Jakubikova; Danka Cholujova; Teru Hideshima; Paulina Gronesova; Andrea Soltysova; Takeshi Harada; Jungnam Joo; Sun-Young Kong; Raphael E Szalat; Paul G Richardson; Nikhil C Munshi; David M Dorfman; Kenneth C Anderson
Journal:  Oncotarget       Date:  2016-11-22

Review 5.  How to Hit Mesenchymal Stromal Cells and Make the Tumor Microenvironment Immunostimulant Rather Than Immunosuppressive.

Authors:  Alessandro Poggi; Serena Varesano; Maria Raffaella Zocchi
Journal:  Front Immunol       Date:  2018-02-19       Impact factor: 7.561

6.  Cellular immunotherapy on primary multiple myeloma expanded in a 3D bone marrow niche model.

Authors:  Maaike V J Braham; Monique C Minnema; Tineke Aarts; Zsolt Sebestyen; Trudy Straetemans; Anna Vyborova; Jurgen Kuball; F Cumhur Öner; Catherine Robin; Jacqueline Alblas
Journal:  Oncoimmunology       Date:  2018-02-22       Impact factor: 8.110

7.  Ex vivo propagation in a novel 3D high-throughput co-culture system for multiple myeloma.

Authors:  Johannes M Waldschmidt; Stefan J Fruttiger; Dagmar Wider; Johannes Jung; Andreas R Thomsen; Tanja N Hartmann; Justus Duyster; Martin J Hug; Kareem A Azab; Manfred Jung; Ralph Wäsch; Monika Engelhardt
Journal:  J Cancer Res Clin Oncol       Date:  2022-01-24       Impact factor: 4.322

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.